On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Cardiomyopathy and Myosin Studies

TopicLeading institutions, researchers & key papers

Cardiomyopathy and Myosin Studies is a topic indexed in ScholarIQ from OpenAlex.

What is known about Cardiomyopathy and Myosin Studies?

ScholarIQrecord summary

This cluster of papers focuses on the diagnosis, management, genetic basis, and clinical outcomes of hypertrophic cardiomyopathy. It explores topics such as cardiomyopathies, myosin mutations, left ventricular non-compaction, sudden death risk, cardiac imaging, titin mutations, dilated cardiomyopathy, and cardiac fibrosis.

How many works does Cardiomyopathy and Myosin Studies have?

ScholarIQindexed works

Cardiomyopathy and Myosin Studies has 221 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Cardiomyopathy and Myosin Studies?

ScholarIQopenalex

The OpenAlex for Cardiomyopathy and Myosin Studies is on the source record.

What are the most-cited papers on Cardiomyopathy and Myosin Studies?

ScholarIQmost cited works
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Perry M Elliott, A Anastasakis, M A Borger, M B Borggrefe, Franco Cecchi, Philippe Charron, Albert Hagège, Antoine Lafont, Giuseppe Limongelli, Heiko Mahrholdt, William J McKenna, Jens Mogensen, P Nihoyannopoulos, Petronella G Pieper, Stefano Nistri, Burkert Pieske, Claudio Rapezzi, Frans H Rutten, Christoph Tillmanns, Hugh Watkins, Stephan Windecker
European Heart Journal. 20144,336 CitationsOPEN ACCESS
Contemporary Definitions and Classification of the Cardiomyopathies
Barry J. Maron, Jeffrey A. Towbin, Gaetano Thiene, Charles Antzelevitch, Domenico Corrado, Donna K. Arnett, Arthur J. Moss, Christine E. Seidman, James B. Young
Circulation. 20063,431 Citations
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
Perry Elliott, B. Andersson, Eloisa Arbustini, Zofia T. Bilińska, Franco Cecchi, Philippe Charron, Olivier Dubourg, Uwe Kühl, Bernhard Maisch, William J. McKenna, Lorenzo Monserrat, Sabine Pankuweit, Claudio Rapezzi, Petar Seferović, Luigi Tavazzi, Andre Keren
European Heart Journal. 20073,014 CitationsOPEN ACCESS
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Bernard J. Gersh, Barry J. Maron, Robert O. Bonow, Joseph A. Dearani, Michael A. Fifer, Mark S. Link, Srihari S. Naidu, Rick A. Nishimura, Steve R. Ommen, Harry Rakowski, Christine E. Seidman, Jeffrey A. Towbin, James E. Udelson, Clyde W. Yancy
Circulation. 20112,115 CitationsOPEN ACCESS
Truncations of Titin Causing Dilated Cardiomyopathy
Daniel S. Herman, Lien Lam, Matthew R.G. Taylor, Libin Wang, Polakit Teekakirikul, Danos C. Christodoulou, Lauren Conner, Steven R. DePalma, Barbara McDonough, Elizabeth Sparks, Debbie Lin Teodorescu, Allison L. Cirino, Nicholas R. Banner, Dudley J. Pennell, Sharon Graw, Marco Merlo, Andrea Di Lenarda, Gianfranco Sinagra, J. Martijn Bos, Michael J. Ackerman, Richard N. Mitchell, Charles E. Murry, Neal K. Lakdawala, Carolyn Y. Ho, Paul J.R. Barton, Stuart A. Cook, Luisa Mestroni, Jonathan G. Seidman, Christine E. Seidman
New England Journal of Medicine. 20121,494 Citations

Where is Cardiomyopathy and Myosin Studies research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Cardiomyopathy and Myosin Studies is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
13%
Hybrid
13%
Bronze
40%
Closed
33%

Related on ScholarIQ

470M+ articles · 14-day free trial